GPCR Stock: Price, Earnings History and SEC Filings
Structure Therapeutics Inc. (GPCR) last traded at $21.87, down 0.32% on the latest session and down 30.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.49 against an analyst estimate of $-0.39, a miss of 25.6%.
$21.87 -0.32%
1 month-30.06%
52-week high$94.90
52-week low$20.50
Volume696,978
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GPCR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.49 | $-0.39 | -25.64% |
| Mar 2026 | May 7, 2026 | $-0.35 | $-0.39 | +10.26% |
| Dec 2025 | Feb 26, 2026 | $-0.49 | $-0.35 | -40.00% |
| Sep 2025 | Nov 6, 2025 | $-0.37 | $-0.36 | -2.78% |
GPCR beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GPCR
SEC filing data is not available right now. You can search for GPCR on SEC EDGAR.
GPCR news
- Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 EarningsOct 27, 2026 · finance.yahoo.com
- How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?Oct 21, 2026 · finance.yahoo.com
- Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026Oct 19, 2026 · finance.yahoo.com
- How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?Oct 19, 2026 · finance.yahoo.com
About Structure Therapeutics Inc.
Structure Therapeutics Inc. (GPCR) is a US-listed public company on Nasdaq.